TSX:TH (Theratechnologies)
About TH
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
Theratechnologies (TSX: TH) Latest News

Investing
Can This Biotech Return 100% in 2019?

Tech Stocks
This Cheap Pharma Stock Just Gave Investors Some Great News

Investing
3 Stocks That Popped on Thursday
Investing
Is Theratechnologies Inc. (TSX:TH) the Healthiest High-Growth Pharma Stock on the TSX?
Investing
5 Non-Cannabis Stocks That Doubled in 2017

Investing
TSX Reaches 16,000: These Are 5 of the Highest-Performing Stocks This Year
Dividend Stocks
5 High-Growth Stocks That Have Seen Sales Triple in 2 Years and Could Still Grow More!
Investing
Wall Street Analyst Gives This 180% Gainer Another 29% Upside: Time to Buy?
❮2